Filing Details

Accession Number:
0001567619-22-016959
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-01 19:04:45
Reporting Period:
2022-08-31
Accepted Time:
2022-09-01 19:04:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611311 P. David Rosenbaum C/O Ardelyx, Inc.
400 Fifth Avenue, Suite 210
Waltham MA 02451
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-31 3,000 $0.62 92,369 No 4 P Indirect By Wife
Common Stock Disposition 2022-09-01 3,000 $0.92 89,369 No 4 S Indirect By Wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Wife
No 4 S Indirect By Wife
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 77,592 Indirect Family Trust
Common Stock 302,458 Direct
Footnotes
  1. Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2022.
  2. The shares are directly held by the Reporting Person's wife.
  3. The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.